Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -213,898 | -107,370 | -395,893 | -290,574 | -190,956 |
| Depreciation Amortization | 13,538 | 4,719 | 21,609 | 16,556 | 10,226 |
| Income taxes - deferred | -477 | N/A | N/A | N/A | N/A |
| Accounts receivable | -33 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,171 | 3,025 | 5,883 | 4,327 | 65 |
| Other Working Capital | -24,299 | -12,829 | -2,892 | -5,895 | -16,749 |
| Other Operating Activity | 28,231 | 12,640 | 78,536 | 60,500 | 45,977 |
| Operating Cash Flow | $-193,767 | $-99,815 | $-292,757 | $-215,086 | $-151,437 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 221,310 | 159,060 | 276,880 | 273,397 | 198,295 |
| PPE Investments | -15,184 | -5,664 | -20,425 | -17,403 | -16,016 |
| Net Acquisitions | -209,509 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-3,383 | $153,396 | $256,455 | $255,994 | $182,279 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 261,427 | 260,101 | 192,799 | 2,224 | 1,999 |
| Other Financing Activity | -2,230 | -1,929 | -2,649 | -2,649 | -2,649 |
| Financing Cash Flow | $259,197 | $258,172 | $190,150 | $-425 | $-650 |
| Exchange Rate Effect | -3,768 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 238,161 | 238,161 | 84,313 | 84,313 | 84,313 |
| End Cash Position | 296,440 | 549,914 | 238,161 | 124,796 | 114,505 |
| Net Cash Flow | $58,279 | $311,753 | $153,848 | $40,483 | $30,192 |
| Free Cash Flow | |||||
| Operating Cash Flow | -193,767 | -99,815 | -292,757 | -215,086 | -151,437 |
| Capital Expenditure | -15,184 | -5,664 | -20,425 | -17,403 | -16,016 |
| Free Cash Flow | -208,951 | -105,479 | -313,182 | -232,489 | -167,453 |